Our studies demonstrate a modest increase in Th1 responses in the autoimmune phase of TLR9-stimulated MPO-pulsed dendritic-cell-induced disease and a large and significant increase in Th17 responses in both the autoimmune and kidney injury phases. The gene discussed is MPO; the disease is glycogen storage disease VI.